TrialJournal for immunotherapy of cancer2019

Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer.

Colby S Shemesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.